Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NRX Pharmaceuticals (NRXP) just unveiled an announcement.
NRx Pharmaceuticals, Inc. is on the hunt for a new CEO with expertise in commercial pharmaceuticals and experience in launching drugs, aligning with their strategic needs as they prepare to submit new drug applications for NRX-100 and NRX-101. Outgoing CEO Stephen Willard recommended this change to better serve shareholders, and he will remain in his role until a suitable successor is found, clarifying that his departure is not due to any operational disagreements.
See more data about NRXP stock on TipRanks’ Stock Analysis page.